Marshelle Smith Warren - Jun 1, 2022 Form 4 Insider Report for SQZ Biotechnologies Co (SQZB)

Role
Chief Medical Officer
Signature
/s/ Lawrence Knopf, Attorney-in-Fact for Marshelle Smith Warren
Stock symbol
SQZB
Transactions as of
Jun 1, 2022
Transactions value $
$0
Form type
4
Date filed
6/3/2022, 04:39 PM
Next filing
Jan 26, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SQZB Stock Option Award $0 +200K $0.00 200K Jun 1, 2022 Common Stock 200K $3.32 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests and becomes exercisable as to 25% of the underlying securities on June 1, 2023 and in 36 substantially equal monthly installments thereafter.